-
Mashup Score: 31
Acute myeloid leukemia (AML) treatment has primarily focused on 7 + 3 chemotherapy, but in the last decade there has been a significant increase in new therapies, mostly targeted agents, approved f…
Source: www.tandfonline.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22Estimated Savings After Stopping TKI Treatment for Patients With CML - 5 month(s) ago
This decision analytical modeling study estimates the financial outcome of discontinuation of tyrosine kinase inhibitor (TKI) therapy among US adult patients with chronic myeloid leukemia (CML) who experience deep molecular response to TKIs.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
Purpose We examined whether having a history of cancer and chronic diseases was associated with guideline-concordant colorectal cancer (CRC) screening utilization. Methods Self-reported data from the 2020 and 2021 Behavioral Risk Factor Surveillance System in Oregon and West Virginia were used. Guideline-concordant CRC screening was the outcome of interest. The exposure was having a personal…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30
Acute myeloid leukemia (AML) treatment has primarily focused on 7 + 3 chemotherapy, but in the last decade there has been a significant increase in new therapies, mostly targeted agents, approved f…
Source: www.tandfonline.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization Georgia Cancer Center, Augusta, GA Princess Margaret Cancer Centre, Toronto, ON Georgia Cancer Center, Augusta, GA Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna McGill University, Montreal, QC Department of Hematolog
Source: haematologica.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 20Faculty - 2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition - 5 month(s) ago
Faculty PresentersHere’s what’s scheduled for the event.December 8, 2023Full Session Title: Medical Crossfire®: Novel BTKi Strategies Transforming Aggressive and Indolent B-Cell MalignanciesIan FlinnProgram Director Tennessee Oncology Catherine C. CoombsAssociate Clinical Professor University of California Irvine Overcoming Racial Disparities in Multiple MyelomaSan Diego Convention CenterFull…
Source: event.gotoper.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4#ESHCML2024 SAVE THE DATE: SEPTEMBER 27-29, 2024 - 6 month(s) ago
26 th Annual John Goldman Conference on CHRONIC MYELOID LEUKEMIA: Biology and Therapy Mark your agenda: September 27-29, 2024 in Prague, Czech Republic Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, François-Xavier Mahon, Danilo Perrotti, Giuseppe Saglio, Charles
Source: mailchi.mpCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37
I’m taking on a huge challenge to support an incredible cause. Please sponsor me by clicking the link. Thanks so much!
Source: icmlf-nepal-2023.inadv.com.auCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36
I’m taking on a huge challenge to support an incredible cause. Please sponsor me by clicking the link. Thanks so much!
Source: icmlf-nepal-2023.inadv.com.auCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36
I’m taking on a huge challenge to support an incredible cause. Please sponsor me by clicking the link. Thanks so much!
Source: icmlf-nepal-2023.inadv.com.auCategories: General Medicine News, Hem/OncsTweet
Just published, a review on safety of targeted therapies for AML with our star residentes from @MCG_AUG Mark Dalgetty & Christian Leurinda. @GACancerCenter @icmlf https://t.co/oEQpMqgqxC